Royal London Asset Management
CVS icon

Royal London Asset Management’s CVS Health CVS Stock Holding History

Royal London Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.6M Sell
663,364
-4,003
-0.6% -$357K 0.13% 149
2026
Q1 		$47.9M Buy
667,367
+2,299
+0.3% +$177K 0.1% 174
2025
Q4 		$52.8M Sell
665,068
-8,881
-1% -$700K 0.11% 160
2025
Q3 		$50.8M Buy
673,949
+114,117
+20% +$7.82M 0.11% 167
2025
Q2 		$38.6M Sell
559,832
-23,769
-4% -$1.56M 0.09% 200
2025
Q1 		$39.5M Buy
583,601
+60,471
+12% +$3.62M 0.09% 194
2024
Q4 		$23.5M Buy
523,130
+3,023
+0.6% +$170K 0.06% 262
2024
Q3 		$32.7M Buy
520,107
+20,679
+4% +$1.21M 0.08% 205
2024
Q2 		$29.5M Buy
499,428
+2,176
+0.4% +$136K 0.08% 200
2024
Q1 		$39.7M Sell
497,252
-10,147
-2% -$775K 0.1% 171
2023
Q4 		$40.1M Buy
507,399
+14,289
+3% +$1.02M 0.11% 157
2023
Q3 		$34.4M Buy
493,110
+15,061
+3% +$1.07M 0.11% 160
2023
Q2 		$33M Buy
478,049
+10,976
+2% +$781K 0.11% 154
2023
Q1 		$34.7M Buy
467,073
+6,401
+1% +$537K 0.14% 132
2022
Q4 		$42.9M Buy
460,672
+16,575
+4% +$1.6M 0.19% 111
2022
Q3 		$42.4M Sell
444,097
-26,349
-6% -$2.61M 0.21% 88
2022
Q2 		$43.6M Buy
470,446
+6,045
+1% +$590K 0.2% 101
2022
Q1 		$47M Buy
464,401
+12,355
+3% +$1.3M 0.18% 108
2021
Q4 		$46.6M Sell
452,046
-19,098
-4% -$1.76M 0.17% 108
2021
Q3 		$40M Sell
471,144
-2,982
-0.6% -$250K 0.16% 122
2021
Q2 		$39.6M Sell
474,126
-14,970
-3% -$1.23M 0.16% 124
2021
Q1 		$36.8M Buy
489,096
+17,912
+4% +$1.3M 0.17% 123
2020
Q4 		$32.2M Sell
471,184
-22,946
-5% -$1.49M 0.17% 122
2020
Q3 		$28.4M Sell
494,130
-1,004
-0.2% -$62.5K 0.17% 118
2020
Q2 		$31.9M Sell
495,134
-16,145
-3% -$1.02M 0.22% 98
2020
Q1 		$30.5M Sell
511,279
-4,825
-0.9% -$322K 0.25% 98
2019
Q4 		$38M Buy
516,104
+11,084
+2% +$778K 0.26% 88
2019
Q3 		$31.9M Buy
505,020
+6,711
+1% +$398K 0.24% 95
2019
Q2 		$27.2M Sell
498,309
-20,835
-4% -$1.12M 0.26% 97
2019
Q1 		$28M Sell
519,144
-24,492
-5% -$1.51M 0.22% 109
2018
Q4 		$35.4M Buy
543,636
+115,950
+27% +$8.66M 0.31% 76
2018
Q3 		$33.7M Sell
427,686
-3,936
-0.9% -$281K 0.34% 69
2018
Q2 		$27.8M Buy
+431,622
New +$28.4M 0.28% 79
2016
Q2 		$34.7M Buy
362,055
+92,055
+34% +$9.17M 0.57% 41
2016
Q1 		$28M Sell
270,000
-127,427
-32% -$12.4M 0.69% 34
2015
Q4 		$39.2M Sell
397,427
-2,317
-0.6% -$227K 0.61% 37
2015
Q3 		$38.6M Buy
+399,744
New +$42M 0.62% 34
2014
Q4 		$35.7M Buy
366,158
+79,507
+28% +$7.01M 0.68% 32
2014
Q3 		$22.9M Buy
286,651
+15,034
+6% +$1.19M 0.58% 38
2014
Q2 		$20.9M Sell
271,617
-6,435
-2% -$486K 0.48% 45
2014
Q1 		$21.4M Sell
278,052
-7,697
-3% -$544K 0.5% 45
2013
Q4 		$19.9M Sell
285,749
-5,391
-2% -$346K 0.5% 43
2013
Q3 		$18.1M Buy
291,140
+3,310
+1% +$197K 0.48% 45
2013
Q2 		$16.5M Buy
+287,830
New +$16.7M 0.48% 46

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Royal London Asset Management's CVS Position: Q2 2026 in Review

Royal London Asset Management reduced its CVS Health (CVS) stake by 0.6% in Q2 2026, selling an estimated $357K and leaving 663,364 shares worth $68.6M. The position accounts for 0.13% of the portfolio, ranked #149.

Royal London Asset Management first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Royal London Asset Management held 663,364 shares of CVS Health worth $68.6M as of Q2 2026.
  • Royal London Asset Management sold 4,003 CVS Health shares in Q2 2026, an estimated $357K.
  • CVS Health made up 0.13% of Royal London Asset Management's portfolio in Q2 2026, its #149 holding.
  • Royal London Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.